Equities analysts expect Safeguard Scientifics, Inc (NYSE:SFE) to post earnings of ($0.39) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings of ($0.81) per share during the same quarter last year, which suggests a positive year over year growth rate of 51.9%. The business is scheduled to report its next earnings results on Thursday, February 27th.
On average, analysts expect that Safeguard Scientifics will report full year earnings of $2.29 per share for the current financial year. For the next fiscal year, analysts forecast that the company will report earnings of ($1.31) per share. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings results on Thursday, November 7th. The asset manager reported ($0.12) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.56) by $0.44.
Institutional investors and hedge funds have recently modified their holdings of the company. NJ State Employees Deferred Compensation Plan raised its holdings in shares of Safeguard Scientifics by 4.6% during the 2nd quarter. NJ State Employees Deferred Compensation Plan now owns 22,833 shares of the asset manager’s stock valued at $275,000 after buying an additional 1,000 shares in the last quarter. Bank of Montreal Can raised its stake in shares of Safeguard Scientifics by 0.3% during the second quarter. Bank of Montreal Can now owns 516,582 shares of the asset manager’s stock worth $6,235,000 after acquiring an additional 1,637 shares in the last quarter. Captrust Financial Advisors lifted its holdings in shares of Safeguard Scientifics by 272.3% in the 2nd quarter. Captrust Financial Advisors now owns 3,008 shares of the asset manager’s stock worth $36,000 after acquiring an additional 2,200 shares during the last quarter. Morgan Stanley lifted its holdings in shares of Safeguard Scientifics by 15.2% in the 2nd quarter. Morgan Stanley now owns 19,979 shares of the asset manager’s stock worth $241,000 after acquiring an additional 2,630 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Safeguard Scientifics by 3.1% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 116,664 shares of the asset manager’s stock valued at $1,409,000 after purchasing an additional 3,520 shares in the last quarter. Hedge funds and other institutional investors own 67.86% of the company’s stock.
NYSE SFE traded up $0.08 during trading hours on Friday, hitting $11.54. The company had a trading volume of 1,016 shares, compared to its average volume of 62,251. The company has a debt-to-equity ratio of 0.02, a quick ratio of 13.03 and a current ratio of 13.03. The firm has a market capitalization of $237.06 million, a price-to-earnings ratio of -15.17 and a beta of 0.84. Safeguard Scientifics has a 52 week low of $7.99 and a 52 week high of $12.91. The firm has a 50 day simple moving average of $11.47 and a 200 day simple moving average of $11.80.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Further Reading: Cost of Equity For A Business, Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.